Quality of life of oropharyngeal cancer patients treated with brachytherapy

Current Oncology Reports

Volumn 11, Issue 2, 2009, Pages 143-150

  Teguh, David N ^b   Levendag, Peter C ^a   Kolkman Deurloo, Inger Karine ^b   Rooij, Peter ^b   Schmitz, Paul I M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137; COBALT 60; IODINE 125; IRIDIUM 192; RADIOISOTOPE; UNCLASSIFIED DRUG; YTTERBIUM 169;

BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DYSPHAGIA; EXTERNAL BEAM RADIOTHERAPY; HUMAN; ORAL SURGERY; OROPHARYNX CANCER; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; REVIEW; TONGUE CANCER; TREATMENT RESPONSE;

BRACHYTHERAPY; DEGLUTITION DISORDERS; HUMANS; OROPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE;

EID: 60349098469     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-009-0021-7     Document Type: Review

References (47)

1. Popovtzer A, Eisbruch A. Advances in radiation therapy of head and neck cancer. Expert Rev Anticancer Ther 2008, 8:633-644.
2. Logemann JA: Update on clinical trials in dysphagia. Dysphagia 2006, 21:116-120.
3. Dornfeld K, Simmons JR, Karnell L, et al.: Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 2007, 68:750-757.
4. Feng FY, Lyden TH, Kim HM, et al.: IMRT aimed at reducing dysphagia: early dose-volume-effect relationships for swallowing structures. Int J Radiat Oncol Biol Phys 2006, 66:S44-S45.
5. Jensen K, Lambertsen K, Grau C: Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007, 85:74-82.
6. Levendag PC, Teguh DN, Voet P, et al.: Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 2007, 85:64-73.
7. Teguh DN, Levendag PC, Noever I, et al.: Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 2008, 72: 1119-1127.
8. Goffinet DR, Fee WE Jr, Wells J, et al.: 192Ir pharyngoepiglottic fold interstitial implants. The key to successful treatment of base tongue carcinoma by radiation therapy. Cancer 1985, 55:941-948.
9. Crook J, Mazeron JJ, Marinello G: Combined external and interstitial implantation for T1 and T2 epidermoid carcinoma of base of tongue: The Creteil experience. Int J Radiat Oncol Biol Phys 1988, 15:105-114.
10. Esche BA, Haie CM, Gerbaulet AP, et al.: Interstitial and external radiotherapy in carcinoma of the soft palate and uvula. Int J Radiat Oncol Biol Phys 1988, 15:619-625.
11. Foote RL, Parsons JT, Mendenhall WM: Is interstitial implantation essential for successful treatment of base of tongue carcinoma? Int J Radiat Oncol Bol Phys 1990, 18:1293-1298.
12. Gerbaulet A, Poetter R, Mazeron JJ: The GEC ESTRO Handbook of Brachytherapy. Brussels, Belgium: European Society for Therapeutic Radiology and Oncology; 2002.
13. Horwitz EM, Frazier AJ, Martinez AA: Excellent functional outcome in patients with squamous cell carcinoma of the base of the tongue treated with external irradiation and interstitial iodine 125 boost. Cancer 1996, 78:948-957.
14. Mazeron JJ, Marinello G, Crook J: Definitive radiation treatment for early stage carcinoma of the soft palate and uvula: The indication for iridium 192 implantation. Int J Radiat Oncol Biol Phys 1987, 13:1829-1837.
15. Pernot M, Hoffstetter S, Pfeiffert D, et al.: Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: Reflection of a series of 1344 patients treated at the time of initial presentation. Otolaryngol Head Neck Surg 1996, 115:519-526.
16. Mazeron JJ, Crook J, Martin M, et al.: Iridium 192 implantation of squamous cell carcinomas of the oropharynx. Am J Otolaryngol 1989, 10:317-321.
17. Pernot M, Hoffstetter S, Peiffert D, et al.: Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: Reflection of a series of 1344 patients treated at the time of initial presentation. Otolaryngol Head Neck Surg 1996, 115:519-526.
18. Levendag P, Nijdam W, Noever I, et al.: Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: Late adverse sequelae and performance status: Can we be more selective and obtain better tissue sparing? Int J Radiat Oncol Biol Phys 2004, 59:713-724.
19. Levendag PC, Schmitz PI, Jansen PP, et al.: Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: First clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 1997, 38:497-506.
20. Vikram B, Hilaris BS: A non-looping afterloading technique for interstitial implants of the base of the tongue. Int J Radiat Oncol Biol Phys 1981, 7:419-422.
21. Vikram B, Strong E, Shah J, et al.: A non-looping afterloading technique for base of tongue implants: Results in the first 20 patients. Int J Radiat Oncol Biol Phys 1985, 11:1853-1855.
22. Harrison LB, Lee HJ, Pfister DG, et al.: Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head Neck 1998, 20:668-673.
23. Housset M, Baillet F, Dessard-Diana B, et al.: A retrospective study of three treatment techniques for T1-T2 base of tongue lesions: Surgery plus postoperative radiation, external radiation plus interstitial implantation and external radiation alone. Int J Radiat Oncol Biol Phys 1987, 13:511-516.
24. Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000, 355:949-955.
25. Argiris A, Karamouzis MV, Raben D, Ferris RL: Head and neck cancer. Lancet 2008, 371:1695-1709.
26. Piccirillo JF, Vlahiotis A: Comorbidity in patients with cancer of the head and neck: Prevalence and impact on treatment and prognosis. Curr Oncol Rep 2006, 8:123-129.
27. Harrison LB, Zelefsky MJ, Pfister DG, et al.: Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997, 19:169-175.
28. Babin E, Sigston E, Hitier M, et al.: Quality of life in head and neck cancers patients: Predictive factors, functional and psychosocial outcome. Eur Arch Otorhinolaryngol 2008, 265:265-270.
29. Pourel N, Peiffert D, Lartigau E, et al.: Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys 2002, 54:742-751.
30. Petruson K, Mercke C, Lundberg LM, et al.: Longitudinal evaluation of patients with cancer in the oral tongue, tonsils, or base of tongue-does interstitial radiation dose affect quality of life? Brachytherapy 2005, 4:271-277.
31. Hammerlid E, Mercke C, Sullivan M, Westin T: A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy. Oral Oncol 1997, 33:189-196.
32. Nijdam W, Levendag PC Noever I, et al.: Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Radiother Oncol 2005, 77:65-72.
33. Poulsen MG, Riddle B, Keller J, et al.: Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone. Radiother Oncol 2008, 87:253-259.
34. Mangar S, Slevin N, Mais K, Sykes A: Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: A retrospective review. Radiother Oncol 2006, 78:152-158.
35. Caudell JJ, Schaner PE, Meredith RF, et al.: Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2008 Jul 15 [Epub ahead of print].
36. Feng FY, Kim HM, Lyden TH, et al.: Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007, 68:1289-1298.
37. Jensen K, Lambertsen K, Grau C: Dysphagia, aspiration and speech problems after radiotherapy for pharyngeal cancer correlate with dose-volume parameters of the supraglottic region. Radiother Oncol 2006, 81:S167.
38. Greene FL, Page DL, Fleming ID, et al.: AJCC Cancer Staging Manual, edn 6. New York: Springer; 2002.
39. van de Pol M, Levendag PC, de Bree RR, et al.: Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue. Brachytherapy 2004, 3:78-86.
40. Bjordal K, de Graeff A, Fayers PM, et al.: A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H& N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 2000, 36:1796-1807.
41. List MA, D'Antonio LL, Cella DF, et al.: The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy head and neck scale - a study of utility and validity. Cancer 1996, 77:2294-2301.
42. Chen AY, Frankowski R, Bishop-Leone J, et al.: The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: The M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001, 127:870-876.
43. Thomadsen B, Houdek P, van der Laarse R, et al.: Treatment planning and optimization. In HDR Brachytherapy: A Textbook. Edited by Nag S. Armonk, NY: Futura; 1994:79-145.
44. Saw CB, Suntharalingam N: Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 1991, 20:135-139.
45. Anderson LL: A "natural" volume-dose histogram for brachytherapy. Med Phys 1986, 13:898-903.
46. Kolkman-Deurloo IK, Visser AG, Niel CG, et al.: Optimization of interstitial volume implants. Radiother Oncol 1994, 31:229-239.
47. Das R: ICRU 58 (Dose and Volume Specification for Reporting Interstitial Therapy), by International Commission on Radiation Units and Measurements. Med Phys 1998, 25:1225.